Lentiviral transduction of human T-lymphocytes with a RANTES intrakine inhibits human immunodeficiency virus type 1 infection
Intrakines, modified intracellular chemokines, offer a novel strategy to prevent cellular entry of HIV-1 by blocking the surface expression of HIV-1 co-receptors. To investigate potential clinical applications of the RANTES-intrakine, we explored the use of HIV-1-based lentiviral vectors for therape...
Saved in:
Published in | Gene therapy Vol. 9; no. 13; pp. 889 - 897 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Basingstoke
Nature Publishing Group
01.07.2002
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!